![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 10
2022
Kaeuferle, Theresa; Stief, Tanja A; Canzar, Stefan; Kutlu, Nayad N; Willier, Semjon; Stenger, Dana; Ferrada‐Ernst, Paulina; Habjan, Nicola; Peters, Annika E; Busch, Dirk H und Feuchtinger, Tobias
(23. Januar 2022):
Genome‐wide off‐target analyses of CRISPR/Cas9‐mediated T‐cell receptor engineering in primary human T cells.
In: Clinical & Translational Immunology, Bd. 11, Nr. 1
[PDF, 2MB]
Stief, Tanja A.; Kaeuferle, Theresa; Müller, Thomas R.; Doring, Michaela; Jablonowski, Lena M.; Schober, Kilian; Feucht, Judith; Dennehy, Kevin M.; Willier, Semjon; Blaeschke, Franziska; Handgretinger, Rupert; Lang, Peter; Busch, Dirk H. und Feuchtinger, Tobias
(2022):
Protective T cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections.
In: Molecular Therapy, Bd. 30, Nr. 1: S. 198-208
2021
Mueller, Thomas R.; Jarosch, Sebastian; Hammel, Monika; Leube, Justin; Grassmann, Simon; Bernard, Bettina; Effenberger, Manuel; Andrae, Immanuel; Chaudhry, M. Zeeshan; Kaeuferle, Theresa; Malo, Antje; Cicin-Sain, Luka; Steinberger, Peter; Feuchtinger, Tobias; Protzer, Ulrike; Schumann, Kathrin; Neuenhahn, Michael; Schober, Kilian und Busch, Dirk H.
(2021):
Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy.
In: Cell Reports Medicine, Bd. 2, Nr. 8, 100374
Willier, Semjon; Rothamel, Paula; Hastreiter, Maximilian; Wilhelm, Jonas; Stenger, Dana; Blaeschke, Franziska; Rohlfs, Meino; Kaeuferle, Theresa; Schmid, Irene; Albert, Michael H.; Binder, Vera; Subklewe, Marion; Klein, Christoph und Feuchtinger, Tobias
(2021):
CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapy.
In: Blood, Bd. 137, Nr. 8: S. 1037-1049
2020
Kaeuferle, Theresa; Deisenberger, Larissa; Jablonowski, Lena; Stief, Tanja A.; Blaeschke, Franziska; Willier, Semjon und Feuchtinger, Tobias
(2020):
CRISPR-Cas9-Mediated Glucocorticoid Resistance in Virus-Specific T Cells for Adoptive T Cell Therapy Posttransplantation.
In: Molecular Therapy, Bd. 28, Nr. 9: S. 1965-1973
Blaeschke, Franziska; Willier, Semjon; Stenger, Dana; Lepenies, Mareike; Horstmann, Martin A.; Escherich, Gabriele; Zimmermann, Martin; Ringeling, Francisca Rojas; Canzar, Stefan; Kaeuferle, Theresa; Rohlfs, Meino; Binder, Vera; Klein, Christoph und Feuchtinger, Tobias
(2020):
Leukemia-induced dysfunctional TIM-3(+)CD4(+) bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients.
In: Leukemia, Bd. 34, Nr. 10: S. 2607-2620
Stenger, Dana; Stief, Tanja A.; Kaeuferle, Theresa; Willier, Semjon; Rataj, Felicitas; Schober, Kilian; Vick, Binje; Lotfi, Ramin; Wagner, Beate; Grünewald, Thomas G. P.; Kobold, Sebastian; Busch, Dirk H.; Jeremias, Irmela; Blaeschke, Franziska und Feuchtinger, Tobias
(2020):
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR.
In: Blood, Bd. 136, Nr. 12: S. 1407-1418
2019
Blaeschke, Franziska; Paul, Milan Cedric; Schuhmann, Martin Ulrich; Rabsteyn, Armin; Schröder, Christopher; Casadei, Nicolas; Matthes, Jakob; Mohr, Christopher; Lotfi, Ramin; Wagner, Beate; Kaeuferle, Theresa; Feucht, Judith; Willier, Semjon; Handgretinger, Rupert; Stevanovic, Stefan; Lang, Peter und Feuchtinger, Tobias
(2019):
Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy.
In: Cytotherapy, Bd. 21, Nr. 9: S. 973-986
Kaeuferle, Theresa; Krauss, Ramona; Blaeschke, Franziska; Willier, Semjon und Feuchtinger, Tobias
(2019):
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation.
In: Journal of Hematology & Oncology, Bd. 12, 13
2018
Blaeschke, Franziska; Stenger, Dana; Kaeuferle, Theresa; Willier, Semjon; Lotfi, Ramin; Kaiser, Andrew Didier; Assenmacher, Mario; Doering, Michaela; Feucht, Judith und Feuchtinger, Tobias
(2018):
Induction of a central memory and stem cell memory phenotype in functionally active CD4(+) and CD8(+) CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19(+) acute lymphoblastic leukemia.
In: Cancer Immunology Immunotherapy, Bd. 67, Nr. 7: S. 1053-1066